Hand holding the newspaper resting on a table with a cup of coffee


Taxonomy Icon
Ivy Brain Tumor Center Announces Initial Results of Pamiparib in Newly-Diagnosed and Recurrent Glioblastoma at the European Society for Medical Oncology (ESMO) 2022 Congress
  • September 10, 2022
Presented today at the ESMO Congress, Dr. Nader Sanai announced initial results in our Phase 0 clinical trial evaluating pamiparib in patients with #glioblastoma (NCT04614909). The interim analysis demonstrated that pamiparib is well-tolerated in glioblastoma patients.
Taxonomy Icon
Ivy Brain Tumor Center Implements New Liquid Biopsy Program to Provide Glioblastoma Patients More Personalized Care
  • September 7, 2022
The Ivy Brain Tumor Center announced its initiation of a ‘Liquid Biopsy’ program to obtain real-time insights into how a patient’s brain tumor is responding to experimental treatment. 
Taxonomy Icon
Brain Tumors, Drug Development and Neurosurgeons: Ending the Losing Streak
  • September 6, 2022
In this Neurosurgery Blog Tumor Series, Dr. Nader Sanai, director of the Ivy Brain Tumor Center, discusses the unique challenges for brain tumor drug development and how the Ivy Center's Phase 0 clinical trials are creating a new paradigm.
Taxonomy Icon
Team at Ivy Brain Tumor Center works to cure ‘deadliest cancer in humans’
  • August 25, 2022
  • Source: ABC15
Dr. Nader Sanai spoke with local news station, ABC15 about new developments in brain cancer research and treatment on the fourth anniversary of Senator John McCain's death.
Taxonomy Icon
Ivy Brain Tumor Center discusses forms of treatment for rare aggressive brain cancer
  • August 25, 2022
  • Source: AZFamily
Dr. Kelly Braun from the Ivy Brain Tumor Center at Barrow Neurological Institute spoke with Good Morning Arizona reporter Tess Rafols, about new developments and treatments for brain cancer.
Taxonomy Icon
Glioblastoma: are Phase 0 trials a window of opportunity in drug development?
  • July 21, 2022
  • Source: Clinical Trials Arena
The Ivy Center's Phase 0 clinical trials provide valuable data on experimental drugs used to treat brain cancer. Chief Operating Officer and Deputy Director of the Ivy Center, Shwetal Mehta, was featured in Clinical Trials Arena discussing how the Ivy Center is at the forefront of this innovative brain cancer research.
Taxonomy Icon
Ivy Brain Tumor Center Announces Launch of Spanish-Language Website
  • June 15, 2022
The Ivy Brain Tumor Center has announced the launch of a new Spanish-language website, recognizing the importance of providing clinical trial information in multiple languages to patients and caregivers in the U.S. and around the world. 
Taxonomy Icon
Arizona man bikes cross country for brain cancer awareness
  • May 6, 2022
  • Source: 12News
Dr. Joe Tedesco is taking the country by storm as he sets out to ride his bike from coast to coast in honor of brain tumor survivor Nate Tomlin. Covered by 12 News, Dr. Tedesco's fundraiser is gaining traction and he has increased his goal to $20,000! Check out the full story!
Taxonomy Icon
Our Bioscience Economy
  • April 1, 2022
  • Source: InBusiness Phoenix Magazine
InBusiness Phoenix Magazine's latest cover story they detail the Ivy Brain Tumor Center as one of the "top-ranked healthcare organizations that provide top-notch care, are innovative and known for research excellence.”
Taxonomy Icon
Ivy Brain Tumor Center Evaluates AZD1390 in Patients Diagnosed with Recurrent Grade IV Gliomas
  • March 20, 2022
  • Source: Onco'Zine
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer, will evaluate evaluate AZD1390 in a Phase 0/1b clinical trial with patients diagnosed with recurrent grade IV gliomas.